Study: NCT01353898

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-1972
Description: MK-1972 will be supplied as 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-1972
Description: MK-1972 will be supplied as 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-1972
Description: MK-1972 will be supplied as 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-1972
Description: MK-1972 will be supplied as 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-1972
Description: MK-1972 will be supplied as 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-1972
Description: MK-1972 will be supplied as 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-1972
Description: Placebo will be supplied as matching 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-1972
Description: Placebo will be supplied as matching 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-1972
Description: Placebo will be supplied as matching 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-1972
Description: Placebo will be supplied as matching 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-1972
Description: Placebo will be supplied as matching 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to MK-1972
Description: Placebo will be supplied as matching 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to MK-1972
Description: Placebo will be supplied as matching 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to MK-1972
Description: Placebo will be supplied as matching 25 and 100 mg capsules, and will be given orally, at a dose dependent on the treatment arm; participants will take ten capsules (active drug and/or placebo) once or twice per day for 10 days